SCHEMBL30945679

SCHEMBL30945679

O=C(CCN1CCc2[nH]c3ccccc3c2C1)N1CCOCC1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.63
▸ KDM4E B2RXH2 2/20 0.63
▸ HPGD P15428 2/20 0.63
▸ TAAR1 Q96RJ0 1/20 0.57
▸ SIGMAR1 Q99720 1/20 0.56
▸ MAPT P10636 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ KDR P35968 1/20 0.53
▸ ACHE P22303 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ BAZ2B Q9UIF8 1/20 0.53
▸ PARP1 P09874 1/20 0.52
▸ CASP1 P29466 2/20 0.52
▸ CASP7 P55210 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ HDAC1 Q13547 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30945688 0.85 KDR (0.57) KDRACHEBAZ2B
SCHEMBL28918971 0.76 KMT2A (0.54) SIGMAR1MAPTGAALMNAPARP1
SCHEMBL30704370 0.75 SIGMAR1 (0.70) ALDH1A1KDM4EHPGDSIGMAR1ACHE
SCHEMBL30945692 0.74 BAZ2B (0.58) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL28468258 0.73 MAPT (0.77) ALDH1A1KDM4EHPGDTAAR1MAPT
SCHEMBL21222687 0.73 TAAR1 (0.72) ALDH1A1KDM4EHPGDTAAR1MAPT
SCHEMBL31228651 0.73 TAAR1 (0.72) ALDH1A1KDM4EHPGDTAAR1MAPT
SCHEMBL7146651 0.72 APAF1 (0.80) ALDH1A1KDM4EHPGDSIGMAR1MAPT
SCHEMBL7105322 0.72 ACHE (0.59) ALDH1A1KDM4EHPGDSIGMAR1ACHE
SCHEMBL30945657 0.72 ACHE (0.70) ALDH1A1KDM4EHPGDSIGMAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS CULLGEN (SHANGHAI), INC. (CN) 2024-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS DCAF1, DDB1, CUL4A ALDH1A1 2985/4885KDM4E 1056/4885HPGD 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback